explore -WSS

explore

author：entertainment 2025-08-19 20:47:32 - browse：858

At some point this summer, the drugmaker Novo Nordisk will release results from a closely watched study that, if successful, could further uncork demand for new obesity medications, streamline insurance coverage for the therapies, and demonstrate long-lasting health benefits.

The Select trial, as the study is called, is the first large, randomized trial to test whether long-term treatment with a weight loss drug can meaningfully improve patients’ cardiovascular health. Novo is testing Wegovy, a weekly injection also sold under the brand name Ozempic for type 2 diabetes, against placebo in the five-year study.

The implications are massive, and not just for Novo. Wegovy is part of a class of medicines that target a hormone called GLP-1, which curbs patients’ appetites. Those drugs have demonstrated an ability to help people lose dramatic amounts of weight in clinical trials, but payers, including Medicare, have been slow to reimburse for them without definitive data on their long-term health benefits.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Readout LOUD podcast: What to know about H5N1 bird flu

knowledge

hotspot

WSS

Laying a path for careers in science

Are embryos people? Reproductive medicine's future depends on the answer

Elisabeth Bik tackles the widespread issue of research misconduct

Study fuels hope CAR

Making AI in medicine accessible to smaller, and rural hospitals

Readout LOUD podcast: What to know about H5N1 bird flu

explore

explore

explore

In Memoriam: Notable people who died in 2023

Use wet bulb globe temperature, not heat index, to protect workers

Wildfire smoke exposes gaps in outdoor worker protections

Doctor of U.S. President Joe Biden says he is fit for duty

Peter Hotez and the public health issue of online harassment

H5N1 bird flu: what we're starting to learn about infection in cows

How one medical school became remarkably diverse

Laying a path for careers in science

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

First recipient of genetically engineered pig kidney has died

hotspot

Doctor of U.S. President Joe Biden says he is fit for duty

Medicare Advantage isn’t working — for anyone

Readout LOUD podcast: brain research, obesity drug sales, Novartis

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

CDC wastewater surveillance dashboard to track bird flu hotspots

Doctor of U.S. President Joe Biden says he is fit for duty

knowledge

hotspot

explore

leisure time